Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01798641 · ClinicalTrials.gov registry record · NA

A Randomized Cross-over Study for Normal Pressure Hydrocephalus

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT01798641: Completed NA study, sponsored by Johns Hopkins University.

NCT01798641 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01798641, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

The goal of our study is to verify the effectiveness of the shunt and to identify the most sensitive criteria to select patients for surgery. The study is designed to assess improvement in walking and balance (gait), urinary function and memory after shunting. In addition, the study aims to identify the most accurate and sensitive tools to measure improvement for our patients.

Interventions

  • DEVICE MIETHKE proGAV® / MIETHKE proSA®

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2013-01
Est. Completion 2017-09-14
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT01798641

The ClinicalTrials.gov registry entry for NCT01798641 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which MIETHKE proGAV® / MIETHKE proSA® is the first listed.

NCT01798641 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01798641 about?

NCT01798641 is a clinical study titled "A Randomized Cross-over Study for Normal Pressure Hydrocephalus". The goal of our study is to verify the effectiveness of the shunt and to identify the most sensitive criteria to select patients for surgery. The study is designed to assess improvement in walking and balance (gait), urinary function and memory after shunting. In addition, the study aims to identify...

What is the current status of trial NCT01798641?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2013-01. Estimated completion is 2017-09-14.

What interventions are being tested in trial NCT01798641?

The interventions under investigation include: MIETHKE proGAV® / MIETHKE proSA® (DEVICE).

Who is sponsoring clinical trial NCT01798641?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.